DermAvance is a privately held, specialty Aesthetic Dermatology Company that is focused on acquiring and developing both prescription and non-prescription products to improve the appearance of aging skin. DermAvance markets 5 different product lines that include Hyalogy a patented nano-hyaluronic acid topical skin care line, Arnika Forte that is a supplement used to help recovery post surgery or aesthetic procedures, Pur-Sil 100% Medical Grade Silicone for scar recovery, Tret-A an advanced retinoid that contains all-trans retinaldehyde lotion, Hydro-Q 4% gel Rx which contains the active form of hydroquinone to lighten the brown spots in skin.
Looking for a particular DermAvance employee's phone or email?
The DermAvance annual revenue was $6 million in 2026.
Keith Greathouse is the Founder, President and CEO of DermAvance.
2 people are employed at DermAvance.
DermAvance is based in Malvern, Pennsylvania.
The NAICS codes for DermAvance are [32, 3254, 325, 32541].
The SIC codes for DermAvance are [28, 283].